Length of stay and treatment‐related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals
Authors:
- Anthony N. AudinoAAAnthony N. Audino
- Yongjie MiaoYMYongjie Miao
- Sarah H. O'BrienSOSarah H. O'Brien
- 15 June 2012
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (3) , 415-419
Abstract
Background: Adolescent and young adult (AYA) cancer patients have been shown to have unique clinical characteristics and inferior outcomes compared to younger patients. More than 2,500 new bone sarcomas are diagnosed yearly in the US, many of whom are AYAs treated at pediatric hospitals. Pediatric providers must understand the impact of increasing age on complications, costs, and outcomes. The study set‐out to determine if AYA patients with bone sarcomas have increased healthcare utilization and treatment‐related complications as compared to younger patients.Procedure: Data were obtained from the Pediatric Health Information System for bone sarcoma admissions at 41 US children's hospitals from 2006 to 2010. Patient demographics and morbidities were compared in patients 0–14 and 15–28 years using two sample t‐tests, Wilcoxon two sample tests, or chi‐squared tests.Results: We identified 835 pediatric and 562 AYA patients with bone sarcomas. Mean length of stay (LOS) was comparable between age groups (4.6 and 4.8 days, P = 0.46), although AYA patients had greater mean pharmaceutical charges ($18,124 vs. $13,637, P < 0.0001). Common treatment‐related complications were similar between groups, with the exceptions that febrile neutropenia admissions were more likely in younger patients, and thrombosis, renal failure, and pain were more common in AYA patients.Conclusions: In US children's hospitals, AYA patients with sarcomas do not have prolonged LOS or an increased risk of the most common treatment‐related complications as compared to younger patients. Chronic pain appears to be a greater burden in AYA patients, and may account for their higher inpatient pharmaceutical costs. Pediatr Blood Cancer 2013; 60: 415–419.Keywords
This publication has 16 references indexed in Scilit:
- Clinical Trial Participation and Time to Treatment Among Adolescents and Young Adults With Cancer: Does Age at Diagnosis or Insurance Make a Difference?Journal of Clinical Oncology, 2011
- The relationship between unmet needs and distress amongst young people with cancerSupportive Care in Cancer, 2011
- Starting an Adolescent and Young Adult Program: Some Success Stories and Some Obstacles to OvercomeJournal of Clinical Oncology, 2010
- Quality Cancer Care for Adolescents and Young Adults: A Position StatementJournal of Clinical Oncology, 2010
- Clinical outcome of children and adults with localized Ewing sarcomaCancer, 2010
- A Comparison of Clinical Trial Enrollment Between Adolescent and Young Adult (AYA) Oncology Patients Treated at Affiliated Adult and Pediatric Oncology CentersJournal of Pediatric Hematology/Oncology, 2009
- Where Adolescents and Young Adults With Cancer Receive Their Care: Does It Matter?Journal of Clinical Oncology, 2007
- Challenges in the recruitment of adolescents and young adults to cancer clinical trialsCancer, 2007
- ADOLESCENT AND YOUNG ADULT (AYA) ONCOLOGY: The First APediatric Hematology and Oncology, 2007
- The Teenage Cancer Trust—advocating a model for teenage cancer servicesEuropean Journal of Cancer, 2003